These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20526632)

  • 1. Consequences and therapy of the metabolic acidosis of chronic kidney disease.
    Kraut JA; Madias NE
    Pediatr Nephrol; 2011 Jan; 26(1):19-28. PubMed ID: 20526632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
    Kraut JA; Kurtz I
    Am J Kidney Dis; 2005 Jun; 45(6):978-93. PubMed ID: 15957126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
    Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
    Trials; 2015 Aug; 16():326. PubMed ID: 26231610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease.
    Kraut JA; Madias NE
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):289-297. PubMed ID: 29031355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis.
    Navaneethan SD; Shao J; Buysse J; Bushinsky DA
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):1011-1020. PubMed ID: 31196951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Acidosis of CKD: An Update.
    Kraut JA; Madias NE
    Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of metabolic acidosis in patients with chronic kidney disease (CKD)].
    Dębowska M; Przedlacki J
    Wiad Lek; 2017; 70(6 pt 2):1197-1200. PubMed ID: 29533913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
    Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA
    J Am Soc Nephrol; 2024 Mar; 35(3):311-320. PubMed ID: 38261535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.
    Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
    Raphael KL
    Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [End stage of chronic kidney disease and metabolic acidosis].
    Klaboch J; Opatrná S; Matoušovic K; Schück O
    Vnitr Lek; 2012; 58(7-8):519-24. PubMed ID: 23067161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
    Bushinsky DA
    Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies.
    Chiu YW; Kopple JD; Mehrotra R
    Semin Nephrol; 2009 Jan; 29(1):67-74. PubMed ID: 19121476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease - Position Statement of the Working Group of the Polish Society of Nephrology.
    Adamczak M; Masajtis-Zagajewska A; Mazanowska O; Madziarska K; Stompór T; Więcek A
    Kidney Blood Press Res; 2018; 43(3):959-969. PubMed ID: 29895022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic acidosis in chronic kidney disease].
    Havlín J; Matoušovic K; Vaňková S; Schück O
    Vnitr Lek; 2016; 62 Suppl 6():30-39. PubMed ID: 28124929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.